Ikris Pharma Network Announces the Availability of Triokris™ (Trientine Dihydrochloride) to Support Patients Living With Wilson’s Disease

January 16, 2026 by Investors and Startups

Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™…